Navigation Links
Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Date:12/7/2011

MINNEAPOLIS, Dec. 7, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President and CFO, will present the Company's business strategy and financial results at the Oppenheimer 22nd Annual Healthcare Conference at 2:10 PM ET on Tuesday, December 13, 2011 at The Waldorf Astoria Hotel in New York.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet.  Those interested in listening to the webcast may access it at http://www.veracast.com/webcasts/opco/healthcare2011/90116388.cfm or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

 

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.


 

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, Treasurer

952.426.6140

 

EVC Group

Doug Sherk/Jenifer Kirtland (Investors), 415.568.9349

Chris Gale (Media), 646.201.5431

 


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Uroplasty Reports Third Quarter Fiscal 2009 Results
2. Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York
3. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
4. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
5. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
6. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
8. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. VIVUS to Present at the Deutsche Bank BioFEST Conference
10. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
11. Verenium to Present at Baird Clean Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... ... 16, 2017 , ... Cambridge Semantics , the leading ... Smart Data Lake® (Anzo SDL) solution was named a finalist in the ... Information Industry Association (SIIA) CODiE Awards. , Finalists represent the best products, ...
(Date:6/15/2017)... ... 15, 2017 , ... New resistant soybean and cotton cropping ... Palmer amaranth and other broadleaf weeds resistant to glyphosate. But scientists with the ... are known to drift and to cause harm to sensitive, off-target broadleaf plants. ...
(Date:6/15/2017)... ... June 15, 2017 , ... The newest exhibition ... journey through creative experimentation and interdisciplinary collaboration. Feature Creep, a solo exhibition by ... opening reception will be held at EKG, located at 3600 Market Street in ...
(Date:6/15/2017)... ... June 15, 2017 , ... DuPont Industrial Biosciences (DuPont) ... speaking at Bloomberg’s 2017 Sustainable Business Summit: Seattle this Thursday, June ... officials on a panel titled “Developing a Corporate Renewables Strategy.” , “Consumers ...
Breaking Biology Technology:
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):